Lung preservation

Seminars in Thoracic and Cardiovascular Surgery

Volumn 16, Issue 4, 2004, Pages 300-308

  de Perrot, Marc ^a   Keshavjee, Shaf ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Lung transplantation; Outcome; Preservation solution; Primary graft failure; Pulmonary edema

Indexed keywords

4 ETHYL 2 HYDROXYIMINO 5 NITRO 3 HEXENAMIDE; ARGININE; CHEMOKINE RECEPTOR ANTAGONIST; COMPLEMENT INHIBITOR; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GINKGOLIDE B; GLYCERYL TRINITRATE; LINSIDOMINE; LUNG SURFACTANT; NITROGEN OXIDE; NITROPRUSSIDE SODIUM; PENTOXIFYLLINE; PLACEBO; PRESERVATION SOLUTION; PROSTACYCLIN; PROSTAGLANDIN E1; TETRAHYDROBIOPTERIN; THROMBOCYTE ACTIVATING FACTOR ANTAGONIST; TP 10; UNCLASSIFIED DRUG;

ARTIFICIAL VENTILATION; CLINICAL STUDY; CLINICAL TRIAL; CORRELATION ANALYSIS; DRUG POTENTIATION; GRAFT DYSFUNCTION; HUMAN; HYPOTENSION; INCIDENCE; ISCHEMIA; LUNG INFLATION; LUNG TRANSPLANTATION; ORGAN DONOR; ORGAN PRESERVATION; OXYGENATION; PATIENT SELECTION; PRESSURE; REPERFUSION; REPERFUSION INJURY; REVIEW; STORAGE TEMPERATURE; TEMPERATURE;

GRAFT SURVIVAL; HUMANS; LUNG; LUNG TRANSPLANTATION; ORGAN PRESERVATION; ORGAN PRESERVATION SOLUTIONS; REPERFUSION INJURY; TIME FACTORS;

EID: 11844258824     PISSN: 10430679     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.semtcvs.2004.09.012     Document Type: Review

References (65)

1. E.P. Trulock L.B. Edwards D.O. Taylor et al. The Registry of the International Society for Heart and Lung Transplantation Twentieth Official Adult Lung and Heart-Lung Transplant Report-2003 J Heart Lung Transplant 22 2003 625-635
2. R.C. King O.A. Binns F. Rodriguez et al. Reperfusion injury significantly impacts clinical outcome after pulmonary transplantation Ann Thorac Surg 69 2000 1681-1685
3. S.M. Fiser C.G. Tribble S.M. et al. Long Ischemia-reperfusion injury after lung transplantation increases risk of late bronchiolitis obliterans syndrome Ann Thorac Surg 73 2002 1041-1047
4. M. de Perrot W. Weder G.A. Patterson et al. Strategies to increase limited donor resources Eur Respir J 23 3 2004 477-482
5. de Perrot M, Snell GI, Babcock W, et al: Strategies to optimize the use of currently available lung donors. J Heart Lung Transplant (in press)
6. D.N. Hopkinson M.S. Bhabra T.L. Hooper Pulmonary graft preservation A worldwide survey of current clinical practice J Heart Lung Transplant 17 1998 525-531
7. S. Fujimura M. Handa T. Kondo et al. Successful 48-hour simple hypothermic preservation of canine lung transplants Transplant Proc 19 1987 1334-1336
8. S.H. Keshavjee F. Yamazaki P.F. Cardoso et al. A method for safe twelve-hour pulmonary preservation J Thorac Cardiovasc Surg 98 1989 529-534
9. H. Date A. Matsumura J.K. Manchester et al. Evaluation of lung metabolism during successful twenty-four-hour canine lung preservation J Thorac Cardiovasc Surg 105 1993 480-491
10. S. Steen P.O. Kimblad T. et al. Sjoberg Safe lung preservation for twenty-four hours with Perfadex Ann Thorac Surg 57 1994 450-457
11. S.H. Keshavjee F. Yamazaki H. et al. Yokomise The role of dextran 40 and potassium in extended hypothermic lung preservation for transplantation J Thorac Cardiovasc Surg 103 1992 314-325
12. F. Sakamaki H. Hoffmann S. et al Munzing Effects of lung preservation solutions on PMN activation in vitro Transpl Int 12 1999 113-121
13. M. Maccherini S.H. Keshavjee A.S. Slutsky et al. The effect of low-potassium-dextran versus Euro-Collins solution for preservation of isolated type II pneumocytes Transplantation 52 1991 621-626
14. S. Suzuki K. Inoue M. Sugita et al. Effects of EP4 solution and LPD solution versus Euro-Collins solution on Na(+)/K(+)-ATPase activity in rat alveolar type II cells and human alveolar epithelial cell line A549 cells J Heart Lung Transplant 19 2000 887-893
15. F. Sakamaki H. Hoffmann C. Muller et al. Reduced lipid peroxidation and ischemia-reperfusion injury after lung transplantation using low-potassium dextran solution for lung preservation Am J Respir Crit Care Med 156 1997 1073-1081
16. M. Struber J.M. Hohlfeld S.et al. Fraund Low-potassium dextran solution ameliorates reperfusion injury of the lung and protects surfactant function J Thorac Cardiovasc Surg 120 2000 566-572
17. S. Fischer A. Matte-Martyn M. de Perrot et al. Low-potassium dextran preservation solution improves lung function after human lung transplantation J Thorac Cardiovasc Surg 121 2001 594-596
18. M. Struber M. Wilhelmi W. Harringer et al. Flush perfusion with low potassium dextran solution improves early graft function in clinical lung transplantation Eur J Cardiothorac Surg 19 2001 190-194
19. C. Muller H. Furst H. Reichenspurner Lung procurement by low-potassium dextran and the effect on preservation injury Munich Lung Transplant Group Transplantation 68 1999 1139-1143
20. T.M. Aziz T.M. Pillay P.A. Corris et al. Perfadex for clinical lung procurement Is it an advance? Ann Thorac Surg 75 2003 990-995
21. F. Rega G. Verleden J. Vanhaecke et al. Switch from Euro-Collins to Perfadex for pulmonary garft preservation resulted in superior outcome in transplant recipients J Heart Lung Transplant 22 2003 S111
22. J.M. Rabanal A.M. Ibanez R. Mons et al. Influence of preservation solution on early lung function (Euro-Collins versus Perfadex) Transplant Proc 35 2003 1938-1939
23. G. Thabut I. Vinatier O. Brugiere et al. Influence of preservation solution on early graft failure in clinical lung transplantation Am J Respir Crit Care Med 164 2001 1204-1208
24. A. Haverich S. Aziz W.C. Scott et al. Improved lung preservation using Euro-Collins solution for flush-perfusion Thorac Cardiovasc Surg 34 1986 368-376
25. M. Sasaki R. Muraoka Y. Chiba et al. Influence of pulmonary arterial pressure during flushing on lung preservation Transplantation 61 1996 22-27
26. H. Tanaka Y. Chiba M. Sasaki et al. Relationship between flushing pressure and nitric oxide production in preserved lungs Transplantation 65 1998 460-464
27. L.S. Wang K. Nakamoto C.M. Hsieh et al. Influence of temperature of flushing solution on lung preservation Ann Thorac Surg 55 1993 711-715
28. J.M. Albes F. Fischer T. Bando et al. Influence of the perfusate temperature on lung preservation Is there an optimum? Eur Surg Res 29 1997 5-11
29. H. Fehrenbach D. Riemann T. Wahlers et al. Scanning and transmission electron microscopy of human donor lungs Fine structure of the pulmonary parenchyma following preservation and ischemia Acta Anat (Basel) 151 1994 220-231
30. C. Muller H. Hoffmann I. Bittmann et al. Hypothermic storage alone in lung preservation for transplantation A metabolic, light microscopic, and functional analysis after 18 hours of preservation Transplantation 63 1997 625-630
31. T. Fukuse T. Hirata T. Nakamura et al. Influence of deflated and anaerobic conditions during cold storage on rat lungs Am J Respir Crit Care Med 160 1999 621-627
32. K.N. DeCampos S. Keshavjee M. Liu et al. Optimal inflation volume for hypothermic preservation of rat lungs J Heart Lung Transplant 17 1998 599-607
33. T. Sakuma C. Tsukano M. Ishigaki et al. Lung deflation impairs alveolar epithelial fluid transport in ischemic rabbit and rat lungs Transplantation 69 2000 1785-1793
34. R. Baretti J. Bitu-Moreno Beyersdorf et al. Distribution of lung preservation solutions in parenchyma and airways Influence of atelectasis and route of delivery J Heart Lung Transplant 14 1995 80-91
35. M. Haniuda S. Hasegawa T. Shiraishi et al. Effects of inflation volume during lung preservation on pulmonary capillary permeability J Thorac Cardiovasc Surg 112 1996 85-93
36. T. Fukuse T. Hirata S. Ishikawa et al. Optimal alveolar oxygen concentration for cold storage of the lung Transplantation 72 2001 300-304
37. H. Date O. Lima A. Matsumura et al. In a canine model, lung preservation at 10 degrees C is superior to that at 4 degrees C A comparison of two preservation temperatures on lung function and on adenosine triphosphate level measured by phosphorus 31-nuclear magnetic resonance J Thorac Cardiovasc Surg 103 1992 773-780
38. A.J. Kirk I.W. Colquhoun J.H. Dark et al. Lung preservation A review of current practice and future directions Ann Thorac Surg 56 1993 990-100
39. M. Struber J.M. Hohlfeld T. Kofidis et al. Surfactant function in lung transplantation after 24 hours of ischemia: Advantage of retrograde flush perfusion for preservation J Thorac Cardiovasc Surg 123 2002 98-103
40. C.Z. Chen R.C. Gallagher P. Ardery et al. Retrograde flush and cold storage for twenty-two to twenty-five hours lung preservation with and without prostaglandin E1 J Heart Lung Transplant 16 1997 658-666
41. A.F. Pierre K.N. DeCampos M. Liu et al. Rapid reperfusion causes stress failure in ischemic rat lungs J Thorac Cardiovasc Surg 116 1998 932-942
42. M. de Perrot Y. Imai V.M. Ranieri et al. Impact of ventilator induced lung injury on the development of reperfusion injury in a rat lung transplant model J Thorac Cardiovasc Surg 124 6 2002 1137-1144
43. M. Ochs H. Fehrenbach I. Nenadic et al. Preservation of intraalveolar surfactant in a rat lung ischaemia/reperfusion injury model Eur Respir J 15 2000 526-531
44. M.E. Erasmus G.J. Hofstede A.H. Petersen et al. Effects of early surfactant treatment persisting for one week after lung transplantation in rats Am J Respir Crit Care Med 156 1997 567-572
45. R.J. Novick J. MacDonald R.A. Veldhuizen et al. Evaluation of surfactant treatment strategies after prolonged graft storage in lung transplantation Am J Respir Crit Care Med 154 1996 98-104
46. M. Strueber J. Niedermeyer G. Warnecke et al. Exogenous surfactant instillation in lung donors to reduce early graft dysfunction J Heart Lung Transplant 22 2003 S142
47. M. Liu L. Tremblay S.D. Cassivi et al. Alterations of nitric oxide synthase expression and activity during rat lung transplantation Am J Physiol Lung Cell Mol Physiol 278 2000 L1071-L1081
48. R.A. Schmid S. Hillinger R. Walter et al. The nitric oxide synthase cofactor tetrahydrobiopterin reduces allograft ischemia-reperfusion injury after lung transplantation J Thorac Cardiovasc Surg 118 1999 726-732
49. T. Suda B.N. Mora F. D'Ovidio et al. In vivo adenovirus-mediated endothelial nitric oxide synthase gene transfer ameliorates lung allograft ischemia-reperfusion injury J Thorac Cardiovasc Surg 119 2000 297-304
50. M.S. Bhabra D.N. Hopkinson T.E. et al. Shaw Modulation of lung reperfusion injury by nitric oxide Impact of inspired oxygen fraction Transplantation 68 1999 1238-1243
51. A. Ardehali H. Laks M.et al. Levine A prospective trial of inhaled nitric oxide in clinical lung transplantation Transplantation 72 2001 112-115
52. M. Meade J.T. Granton A. Matte-Martyn et al. A randomized trial of inhaled nitric oxide to prevent ischemia-reperfusion injury after lung transplantation Am J Respir Crit Care Med 167 2003 1483-1489
53. A. Chapelier J. Reignier M. Mazmanian et al. Amelioration of reperfusion injury by pentoxifylline after lung transplantation J Heart Lung Transplant 14 1995 676-683
54. S. Murakami E.A. Bacha P. Herve et al. Inhaled nitric oxide and pentoxifylline in rat lung transplantation from non-heart beating donors J Thorac Cardiovasc Surg 113 1997 821-829
55. G. Thabut O. Brugiere G. Leseche et al. Preventive effect of inhaled nitric oxide and pentoxifylline on ischemia/reperfusion injury after lung transplantation Transplantation 71 2001 1295-1300
56. M. de Perrot S. Fischer M. Liu et al. Prostaglandin E1 protects lung transplants from ischemia-reperfusion injury: A shift from pro- to anti-inflammatory cytokines Transplantation 72 2001 1505-1512
57. M. Aoe G.D. Trachiotis K. Okabayashi et al. Administration of prostaglandin E1 after lung transplantation improves early graft function Ann Thorac Surg 58 1994 655-661
58. Y. Matsuzaki T.K. Waddell J.D. Puskas et al. Amelioration of post-ischemic lung reperfusion injury by prostaglandin E1 Am Rev Respir Dis 148 1993 882-889
59. T. Wittwer M. Grote P. Oppelt et al. Impact of PAF antagonist BN 52021 (Ginkolide B) on post-ischemic graft function in clinical lung transplantation J Heart Lung Transplant 20 2001 358-363
60. J.M. Grino BN 52021: A platelet activating factor antagonist for preventing post-transplant renal failure: A double-blind, randomized study. The BN 52021 Study Group in Renal Transplantation Ann Intern Med 121 1994 345-347
61. A.F. Pierre A.M. Xavier M. Liu et al. Effect of complement inhibition with soluble complement receptor 1 on pig allotransplant lung function Transplantation 66 1998 723-732
62. R.A. Schmid A. Zollinger T. Singer et al. Effect of soluble complement receptor type 1 on reperfusion edema and neutrophil migration after lung allotransplantation in swine J Thorac Cardiovasc Surg 116 1998 90-97
63. Keshavjee S, Davis RD, Zamora MR, et al: A randomized placebo controlled trial of complement inhibition in ischemia-reperfusion injury after lung transplantation in humans. J Thorac Cardiovasc Surg (in press)
64. M. de Perrot Y. Sekine S. Fischer et al. Interleukin-8 release during early reperfusion predicts graft function in human lung transplantation Am J Respir Crit Care Med 165 2002 211-215
65. A.J. Fisher S.C. Donnelly N. et al. Hirani Elevated levels of interleukin-8 in donor lungs is associated with early graft failure after lung transplantation Am J Respir Crit Care Med 163 2001 259-265